Original news and analysis on international IP policy
United States Trade Representative Michael Froman today said biologics remain one of the biggest unresolved issues in getting the Trans-Pacific Partnership passed in the US Congress. He called biologics an intellectual property rights issue and said the administration is working with Congress and industry to resolve concerns without reopening the trade deal completed last autumn.
Last year, amid protests from some World Intellectual Property Organization members, a new treaty was adopted to protect geographical indications, broadening an existing treaty. One of the objections of some was that the existing treaty was not financially sustainable, and was piggybacking on other WIPO income-generating treaties. Last week, members of the treaty went over possible solutions to bring money into the system. Italy and France, the biggest beneficiaries, committed actual funds.
NAIROBI, Kenya - As start-up and innovation centres spring up across Africa, Kenya - which birthed the continent’s tech movement - is emerging as one of its leading innovation nuclei. But concerns are intensifying here that young inventors are losing their innovations to conglomerates, in what is alleged as intellectual property theft or abuse.
The United States Copyright Office is examining how provisions of the Digital Millennium Copyright Act (DMCA) and the 1976 Copyright Act are working and whether any changes, legislative or otherwise, are needed. Not surprisingly, there are broad differences of opinion among rights owners, public interest groups, users of copyrighted works and the high-tech community on both questions.
Prices for drugs have long been a problem for developing countries but now have become out of reach for many in developed countries, sparking policy debates and efforts to address it. One of the top figures in the patent monetization business, industry maverick Erich Spangenberg offers a lively opinion on the underlying problem and how to fix it. To start? Stop granting patent extensions for minor changes.
A revised version of what is hoped by a large number of World Intellectual Property Organization members to become a treaty protecting genetic resources from misappropriation was issued today.
Last week, the World Intellectual Property Organization held a seminar on intellectual property and genetic resources. For over a decade, WIPO members have been discussing ways to protect genetic resources and associated traditional knowledge from misappropriation. The seminar allowed speakers from different regions and interests to offer their views on the topic.
"Tobacco-related illness is one of the biggest public health threats the world has ever faced," according to the World Health Organization, and plain packaging of tobacco products can save lives, it said. The theme of this year's no-tobacco day, today, is: Get ready for plain packaging, as the WHO is calling for countries to introduce plain packaging in their territories.
Medicines for Europe, representing the generic, biosimilar, and medicines in Europe, announced today during a side event at the World Health Assembly, that it joined the Global Campaign to Fight Fake Medicines.
The European Union trade secrets directive passed its final hurdle on 27 May when EU governments backed compromise text approved by the European Parliament on 14 April. Once the law has been formally published, member states will have up to two years to incorporate its provisions into domestic law.
Fashion in the US generates over $330 billion in annual revenues, but it is more than a business. Fashion is a well-recognized art, displayed in numerous museum exhibitions throughout the world. This art, however, receives little IP protection in the US. But a case before the US Supreme Court could change that.
Owais Hassan Shaikh writes: According to the section of US law on Special 301 reports, a country may be considered a priority foreign country even when it is fully compliant with the WTO Agreement on the Trade-Related Aspects of Intellectual Property Rights (TRIPS), the main multilateral agreement on IP rights today. Hence, this legislation and the determinations made in the Special 301 reports prioritize protection of commercial interests of the US nationals.